Position in EOLS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$186,013
-$87,028 QoQ
Shares Held
45,259
+10.2% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $39,823,834 across 16 Drug Manufacturers - Specialty & Generic names. EOLS ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
305,467 | $7,309,824 | |
| 2 | ZTS |
Zoetis Inc.
|
57,358 | $6,780,288 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
164,003 | $4,939,769 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
241,293 | $4,468,745 | |
| 5 | ALKS |
Alkermes plc.
|
81,988 | $2,899,094 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
4,828 | $2,862,906 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
11,857 | $1,562,041 | |
| 8 | HLN |
Haleon plc
|
155,748 | $1,559,036 |
All Filings in EOLS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $186,013 | 45,259 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $273,041 | 41,059 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $167,376 | 27,260 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $258,339 | 28,050 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||